Skip to main content
Medinice S.A. logo

Medinice S.A. — Investor Relations & Filings

Ticker · ICE ISIN · PLMDNCE00016 LEI · 259400LGO9UDV1Y18Z11 WAR Manufacturing
Open in API
Filings indexed 761 across all filing types
Latest filing 2024-03-28 Regulatory Filings
Country PL Poland
Listing WAR ICE

About Medinice S.A.

https://www.medinice.pl/?lang=2

Medinice S.A. is a medical technology company focused on the development and commercialization of innovative, minimally invasive solutions in the fields of cardiology and cardiac surgery. The company's mission is to create patient-focused technologies that improve the quality of life for individuals with cardiac diseases. Its portfolio consists of advanced medical devices, including Class III devices, which undergo a full research, development, and clinical trial process before market introduction. Key projects include CoolCryo, a cryoablation system; AtriClamp, for left atrial appendage closure; and PacePress, a specialized compression band used after cardiac device implantation procedures.

Recent filings

Filing Released Lang Actions
Oświadczenia Rady Nadzorczej_podpisane
Regulatory Filings Classification · 95% confidence The document text provided is an XML structure containing metadata and encoded content, specifically referencing Polish regulatory identifiers ('EPUAP-----/podpisanyPlik') and containing base64 encoded attachments. The attachments themselves are identified as DOCX files (Word documents) with names suggesting a formal document related to 'Rady Nadzorczej Medinice S.A.' (Supervisory Board of Medinice S.A.) from 2023. The overall structure strongly suggests a submission or filing made through an electronic platform (EPUAP) that packages the actual report content within the submission envelope. Given the length (over 50,000 characters) and the nature of the encoded content (a DOCX file, likely the full report or presentation), this is not a simple announcement (RPA/RNS). Since the content is a formal, comprehensive document (implied by the DOCX attachment and the context of a Supervisory Board document, which often relates to annual or interim reporting, or governance), and it is not explicitly a 10-K, AR, or IR, the most appropriate classification for a comprehensive, non-standard regulatory document that is being formally submitted is the general 'Regulatory Filings' (RNS) category, as it represents the submission wrapper for a specific regulatory or corporate document that doesn't fit the primary financial report codes (10-K, IR). However, if the content of the DOCX is a presentation or detailed report, 'IP' (Investor Presentation) or 'CGR' (Governance Information) might be considered. Given the ambiguity and the structure being a 'Podpisany plik' (Signed file) submission wrapper, RNS is the safest fallback for a non-standard regulatory submission.
2024-03-28 Polish
Oświadczenia Rady Nadzorczej
Board/Management Information Classification · 95% confidence The document text provided is primarily composed of HTML structure, CSS styles, and font data, indicating it is a conversion artifact (likely from a PDF using pdf2htmlEX) rather than a standard corporate filing document itself. The title tag, "ICE_Oswiadczenia_Rady_Nadzorczej_pl.xhtml", suggests the original content relates to 'Statements of the Supervisory Board' in Polish. Since the actual content of the filing is not present, and the provided text is just the wrapper/rendering code, it cannot be classified as a specific financial report (like 10-K, ER, IR, etc.). According to Rule 2, if the document is extremely short and announces a report, it should be RPA or RNS. However, this document is very long (540k chars) but contains no substantive content, only formatting. In cases where the actual content is missing and only metadata/formatting remains, the most appropriate fallback for an unclassifiable regulatory document is 'Regulatory Filings' (RNS), as it represents a general regulatory announcement wrapper that failed to render the core content, or it is a miscellaneous filing that doesn't fit other categories.
2024-03-28 Polish
List Zarządu do Akcjonariuszy_podpisany
Director's Dealing Classification · 95% confidence The provided document text consists almost entirely of XML structures related to digital signatures (Signatures, SignedInfo, SignatureValue, KeyInfo, X509Data, Object, QualifyingProperties). Crucially, within the 'Object' section, there is a 'DigestValue' referencing a file named 'ICE_List_Zarzadu_GK_2023_pl.xhtml'. The presence of XML digital signatures (often used for regulatory compliance or official document integrity) combined with the reference to an 'xhtml' file suggests this is not the primary report content itself, but rather a wrapper or metadata file associated with a signed document. The document length is very large (1.6 million characters), but the visible content is just the signature block. Since the content points to a specific document ('ICE_List_Zarzadu_GK_2023_pl.xhtml') and the visible text is only the signature block, this strongly suggests an announcement or filing related to the publication of a signed document, rather than the full report (like 10-K or IR). Given the options, this structure is most characteristic of a general Regulatory Filing (RNS) or potentially a Report Publication Announcement (RPA) if it were shorter and explicitly stated the report was attached. Since the content is highly technical (XML signature block) and doesn't explicitly announce publication, RNS is the most appropriate fallback for a technical regulatory artifact that doesn't fit other specific categories.
2024-03-28 Polish
List Zarządu do Akcjonariuszy
Board/Management Information Classification · 95% confidence The document text provided is heavily dominated by HTML and CSS code, indicating it is a rendered or converted document, likely from a PDF, as suggested by the presence of 'pdf2htmlEX' in the CSS comments. The title tag within the HTML head is "List_Zarzadu_2023_pl.xhtml". The Polish word 'Zarządu' translates to 'Board of Directors' or 'Management'. This strongly suggests the document contains information about the company's board or management structure, potentially a list of members for the year 2023. Based on the provided definitions, the most fitting category for information regarding the board of directors or senior management is 'Board/Management Information' (MANG). The document length is substantial (over 1.2 million characters), suggesting it is the content itself, not just a brief announcement (ruling 2 does not apply).
2024-03-28 Polish
Otrzymanie ochrony patentowej od Urzędu Patentowego Indii na wynalazek "PacePress" - Content (PL)
Regulatory Filings Classification · 100% confidence The document text is very short (550 characters) and announces that the Management Board of Medinice S.A. received notification of a patent grant from the Indian Patent Office for an invention called 'PNEUMATIC COMPRESSION BANDAGE' ('PacePress'). This is a specific announcement regarding intellectual property/innovation, which does not fit neatly into the primary financial reporting categories (10-K, IR, ER). While it relates to the company's assets, it is not a general financial report, a management change, or a dividend notice. Given the specific nature of announcing a patent grant, and lacking a dedicated 'Intellectual Property' code, the most appropriate general category for specific, non-standard regulatory/corporate news that isn't a standard financial filing or management change is the fallback category, Regulatory Filings (RNS).
2024-02-26 Polish
Zgoda URPL na przeprowadzenie Badania Klinicznego dla CoolCryo - Content (PL)
Regulatory Filings Classification · 95% confidence The document is a short announcement (1866 characters) from the Management Board of Medinice S.A. regarding receiving approval from the Office for Registration of Medicinal Products (URPL) to conduct a clinical trial for the CoolCryo system. It cites specific Polish and EU regulations related to medical devices and clinical trials. Crucially, the last sentence states: "O oficjalnym rozpoczęciu badań Spółka powiadomi w osobnym komunikacie" (The Company will notify about the official commencement of the studies in a separate announcement). This structure—announcing a regulatory event and stating future communication about the actual start—is characteristic of a general regulatory disclosure that doesn't fit the specific financial report types (10-K, IR, ER, etc.). Given the nature of the announcement (regulatory approval for a medical device trial) and its brevity, it best fits the general 'Regulatory Filings' category (RNS) as a miscellaneous, non-standard filing, or potentially 'LTR' if viewed as a significant legal/regulatory development, but RNS is the safer fallback for non-standard regulatory news.
2024-02-19 Polish

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.